{"entity":{"type":"insider","cik":"0001855298","url":"/insider/0001855298","json_url":"/insider/0001855298.json","name":"Merendino Lauren","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":8,"first":"2022-04-21","last":"2026-02-18","span_basis":"filed_date"},"name_variants":[{"name":"Merendino Lauren","source":"filing","n_filings":8,"first_seen":"2022-04-21","last_seen":"2026-02-18"}],"transactions":[{"id":5753642,"accession":"0001855298-26-000004","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001855298-26-000004","line_url":"/filing/0001855298-26-000004#line-5","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001855298","owner_name":"Merendino Lauren","owner_url":"/insider/0001855298","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5814.0,"shares_display":"5,814","price_per_share":11.6009,"price_display":"11.60","price_state":"stated","total_value":67447.6326,"total_display":"67,447.63","shares_owned_after":60157.0,"shares_owned_after_display":"60,157","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-17","filed_date":"2026-02-18","scope":"insider"},{"id":4686351,"accession":"0001855298-25-000007","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001855298-25-000007","line_url":"/filing/0001855298-25-000007#line-4","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001855298","owner_name":"Merendino Lauren","owner_url":"/insider/0001855298","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3726.0,"shares_display":"3,726","price_per_share":8.9147,"price_display":"8.91","price_state":"stated","total_value":33216.1722,"total_display":"33,216.17","shares_owned_after":50809.0,"shares_owned_after_display":"50,809","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-17","filed_date":"2025-11-18","scope":"insider"},{"id":4770949,"accession":"0001415889-25-022376","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-25-022376","line_url":"/filing/0001415889-25-022376#line-4","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001855298","owner_name":"Merendino Lauren","owner_url":"/insider/0001855298","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3766.0,"shares_display":"3,766","price_per_share":6.7671,"price_display":"6.77","price_state":"stated","total_value":25484.8986,"total_display":"25,484.90","shares_owned_after":41931.0,"shares_owned_after_display":"41,931","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-18","filed_date":"2025-08-19","scope":"insider"},{"id":4770286,"accession":"0001415889-25-013687","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-25-013687","line_url":"/filing/0001415889-25-013687#line-4","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001855298","owner_name":"Merendino Lauren","owner_url":"/insider/0001855298","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3927.0,"shares_display":"3,927","price_per_share":6.2579,"price_display":"6.26","price_state":"stated","total_value":24574.7733,"total_display":"24,574.77","shares_owned_after":35161.0,"shares_owned_after_display":"35,161","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-16","filed_date":"2025-05-19","scope":"insider"},{"id":8701069,"accession":"0001209191-23-004283","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-004283","line_url":"/filing/0001209191-23-004283#line-1","is_derivative":false,"issuer_cik":"0001679082","issuer_name":"Myovant Sciences Ltd.","issuer_ticker":"MYOV","issuer_name_source":null,"issuer_url":"/issuer/0001679082","owner_cik":"0001855298","owner_name":"Merendino Lauren","owner_url":"/insider/0001855298","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2008.0,"shares_display":"2,008","price_per_share":26.89,"price_display":"26.89","price_state":"stated","total_value":53995.12,"total_display":"53,995.12","shares_owned_after":169538.0,"shares_owned_after_display":"169,538","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-18","filed_date":"2023-01-20","scope":"insider"},{"id":6987977,"accession":"0001209191-22-054197","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-054197","line_url":"/filing/0001209191-22-054197#line-1","is_derivative":false,"issuer_cik":"0001679082","issuer_name":"Myovant Sciences Ltd.","issuer_ticker":"MYOV","issuer_name_source":null,"issuer_url":"/issuer/0001679082","owner_cik":"0001855298","owner_name":"Merendino Lauren","owner_url":"/insider/0001855298","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1703.0,"shares_display":"1,703","price_per_share":25.2,"price_display":"25.20","price_state":"stated","total_value":42915.6,"total_display":"42,915.60","shares_owned_after":171546.0,"shares_owned_after_display":"171,546","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-18","filed_date":"2022-10-20","scope":"insider"},{"id":6852891,"accession":"0001209191-22-042690","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-042690","line_url":"/filing/0001209191-22-042690#line-1","is_derivative":false,"issuer_cik":"0001679082","issuer_name":"Myovant Sciences Ltd.","issuer_ticker":"MYOV","issuer_name_source":null,"issuer_url":"/issuer/0001679082","owner_cik":"0001855298","owner_name":"Merendino Lauren","owner_url":"/insider/0001855298","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1704.0,"shares_display":"1,704","price_per_share":12.87,"price_display":"12.87","price_state":"stated","total_value":21930.48,"total_display":"21,930.48","shares_owned_after":173249.0,"shares_owned_after_display":"173,249","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-18","filed_date":"2022-07-20","scope":"insider"},{"id":6624235,"accession":"0001209191-22-025172","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-025172","line_url":"/filing/0001209191-22-025172#line-1","is_derivative":false,"issuer_cik":"0001679082","issuer_name":"Myovant Sciences Ltd.","issuer_ticker":"MYOV","issuer_name_source":null,"issuer_url":"/issuer/0001679082","owner_cik":"0001855298","owner_name":"Merendino Lauren","owner_url":"/insider/0001855298","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7049.0,"shares_display":"7,049","price_per_share":10.45,"price_display":"10.45","price_state":"stated","total_value":73662.05,"total_display":"73,662.05","shares_owned_after":174953.0,"shares_owned_after_display":"174,953","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-19","filed_date":"2022-04-21","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001845337","name":"Day One Biopharmaceuticals, Inc.","url":"/issuer/0001845337","role":"Officer (Chief Commercial Officer)","n_filings":4,"first_seen":"2025-05-19","last_seen":"2026-02-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001679082","name":"Myovant Sciences Ltd.","url":"/issuer/0001679082","role":"Officer (Chief Commercial Officer)","n_filings":4,"first_seen":"2022-04-21","last_seen":"2023-01-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001855298","retrieved_at":"2026-08-21T17:40:58+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}